Etanercept, by Wyeth. Enbrel was initially launched in November 1998, and in addition to psoriatic arthritis, it is also approved for the following indications: reducing the signs and symptoms and inhibiting the progression of structural damage in patients with moderately to severely active rheumatoid arthritis (RA), and for reducing signs and symptoms in patients four years of age and older with moderately to severely active polyarticular-course juvenile rheumatoid arthritis.

Etanercept, by Wyeth. What is this drug used for? Etanercept belongs to the class of medications called biological response modifiers (biologics) or TNF blockers. It is used to treat:

Infliximab, by Schering-Plough. How does it work? Remicade infusion contains the active ingredient infliximab, which is a type of medicine called a monoclonal antibody. It works by suppressing part of the immune system and modifying the process of inflammation.